Clinical Trials Directory

Trials / Completed

CompletedNCT07272408

Remote Ischemic Conditioning in Patients Undergoing Primary Percutaneous Coronary Intervention

Impact of Remote Ischemic Conditioning in Patients Undergoing Primary Percutaneous Coronary Intervention

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
2 (actual)
Sponsor
Helwan University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This study aimed to detect the effects of remote ischemic conditioning on infarct size, global contractility, morbidity, mortality, and renal function in patients undergoing primary percutaneous coronary intervention.

Detailed description

Myocardial infarction (MI) generally refers to segmental (regional) myocardial necrosis, typically endocardial in location, secondary to occlusion of an epicardial artery. Primary percutaneous coronary intervention (PPCI) is a reperfusion therapy that is carried out in patients who usually have ST-segment elevation MI (STEMI) within a specific time window. During ischemia, metabolic acidosis occurs due to anaerobic metabolism, and ischemic injury ensues. After restoration of blood supply, reactive oxygen species (ROS) production and local inflammation increase secondary injury.

Conditions

Interventions

TypeNameDescription
PROCEDURERemote ischemic conditioningRemote ischemic conditioning (RIC) was applied to those patients.
PROCEDURENormal primary percutaneous coronary interventionPatients followed the standard primary percutaneous coronary intervention pathway.

Timeline

Start date
2022-09-01
Primary completion
2023-12-30
Completion
2023-12-30
First posted
2025-12-09
Last updated
2025-12-09

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07272408. Inclusion in this directory is not an endorsement.